Events
Move to help bolster efforts to position emirate as leading and highly preferred destination for health rejuvenation
Recipharm will publish its interim report for January-September 2018 on the 8th November at 07:45 am CET.
Clinical Data Managers in Free Webinar
VTT and Dyadic International, Inc. today announced that VTT scientists will present the excellent results in their collaboration over the past two years at two international conferences: AAPS PharmSci on November 7th in Washington DC and PEGS Europe on November 14th in Lisbon.
Microbiotica announces that it has been named Life Sciences Company of the Year at the Cambridge Independent Awards, which took place last night at the Hilton Cambridge City Centre Hotel.
New Data Demonstrate the Clinical Performance of the Prolaris® and myRisk® Hereditary Cancer Genetic Tests in Men with Prostate Cancer
With a patient-centric focus, Ipsen Biopharmaceuticals is on a mission to improve patients’ lives, leveraging its global reach and placing a strategic focus on external innovation.
Syndax Pharmaceuticals, Inc. today announced that the Company’s Menin-MLLr program will be featured during two presentations at the 60th American Society of Hematology (ASH) Annual Meeting being held December 1-4, 2018 in San Diego, California.
Webinar transcription with key takeaways available on the National Nanotechnology Initiative website (https://bit.ly/2OgylYP)
MOR208 (L-MIND): Interim data from phase 2 L-MIND study of MOR208 plus lenalidomide in 81 patients with relapsed/refractory DLBCL accepted for oral presentation
PRESS RELEASES